Are there medications that remove amyloid deposits from muscles and nerves in wild-type ATTR amyloidosis?
Currently, there are no FDA-approved medications specifically designed to remove existing amyloid deposits from muscles and nerves in wild-type ATTR amyloidosis. The available treatments focus on preventing new amyloid Show Full Answer
Are there medications that remove amyloid deposits from muscles and nerves in wild-type ATTR amyloidosis?
Currently, there are no FDA-approved medications specifically designed to remove existing amyloid deposits from muscles and nerves in wild-type ATTR amyloidosis. The available treatments focus on preventing new amyloid buildup rather than clearing deposits that have already formed.
Researchers are studying whether a medication called PRX004 might help remove amyloid proteins in people with hereditary or wild-type ATTR amyloidosis, but this is still in the research phase.
The FDA-approved medications for wild-type ATTR work by stabilizing the TTR protein to slow or prevent further amyloid buildup. These include:
* Acoramidis (Attruby)
* Tafamidis (Vyndamax)
* Tafamidis meglumine (Vyndaqel)
* Vutrisiran (Amvuttra)
Wild-type ATTR typically affects the heart rather than nerves, so most treatments target cardiac symptoms. If you're experiencing muscle or nerve symptoms, talk with your healthcare team about managing those specific issues alongside your heart-focused treatment plan.
March 19
Join
Your Privacy Choices
